|
Market Closed -
Nasdaq
16:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 30.06 USD | +7.36% |
|
+3.66% | +30.64% |
| 08-10 | Damora Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-05 | Damora Therapeutics Begins Trial of DMR-001 in ET, Myelofibrosis | MT |
Stock exchange
Quotes 5-day view: Damora Therapeutics, Inc.
Delayed Quote Nasdaq
| 2026-08-31 | 2026-09-01 | 2026-09-02 | 2026-09-03 | 2026-09-04 | |
|---|---|---|---|---|---|
| Last | US$28.18 | US$28.14 | US$28.18 | US$28.00 | US$30.06 |
| Volume | 497,024 | 272,797 | 462,945 | 328,156 | 295,830 |
| Change | -2.83% | -0.14% | +0.14% | -0.64% | +7.36% |
| Opening | US$28.93 | US$28.10 | US$28.36 | US$28.52 | US$27.49 |
| High | US$28.93 | US$28.45 | US$29.38 | US$28.60 | US$30.35 |
| Low | US$26.53 | US$27.12 | US$27.82 | US$27.40 | US$27.39 |
Performance
| 1 day | +7.36% | ||
| 1 week | +3.66% | ||
| Current month | +6.67% | ||
| 1 month | +0.13% | ||
| 3 months | +34.74% | ||
| 6 months | +1.28% | ||
| Current year | +30.64% | ||
| 1 year | +902.00% | ||
| 3 years | +103.80% | ||
| 5 years | -72.73% |
Volumes
marketsDaily volume
295,832
Estimated daily volume
295,832
Avg. Volume 20 sessions
319,835
Daily volume ratio
0.92
Avg. Volume 20 sessions USD
9,614,240.1
Record volume 1
77,432,222
Record volume 2
54,188,234
Record volume 3
43,784,010
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
1,728,594,532
Net sales (USD)
0
Number of employees
7
Sales / Employee (USD)
0
Free-Float
92.4 %
Free-Float capitalization (USD)
1,597,224,972
Average Daily Capital Traded
0.56%
Indicators
Moving average 5 days
28.51
Moving average 20 days
30.12
Moving average 50 days
29.49
Moving average 100 days
26.77
Price spread / (MMA5)
-5.15%
Price spread / (MMA20)
+0.21%
Price spread / (MMA50)
-1.89%
Price spread / (MMA100)
-10.93%
RSI 9 days
32.01
RSI 14 days
40.34
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.36% | +3.66% | +902.00% | +103.80% | 1.73B | |
| -2.54% | -2.84% | -1.90% | +14.52% | 50.35B | |
| -0.40% | +1.03% | +439.20% | +499.20% | 45.2B | |
| -1.42% | +2.30% | +45.46% | +19.36% | 44.71B | |
| -1.22% | -2.31% | +12.40% | +71.48% | 41.24B | |
| +0.53% | -1.36% | +16.04% | +48.23% | 33.08B | |
| -0.21% | +9.14% | - | - | 17.81B | |
| -0.35% | -1.56% | +22.59% | +116.19% | 16.56B | |
| -1.01% | +0.50% | +15.83% | +27.98% | 14.82B | |
| -1.65% | -1.03% | +77.75% | +37.63% | 14B | |
| Average | -0.09% | +0.81% | +169.93% | +104.27% | 27.95B | |
| Weighted average by Cap. | -0.99% | +0.28% | +99.69% | +121.32% |
Historical Quotes: Damora Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
dd8911eb0d2560ec2d65bd0fef04450.PrdM-htu2pAl_24NdzCJAjhhxEAfFkMuoH_UZH4VGRI.a_k1vX4xmP0XlVlUH2PiSGwGtXlLfyh37RqmJiEmYWdE3zqpLDeO9QiKNw
| Date | Price | Volume | Total |
|---|---|---|---|
| 16:00:00 | 30.06 | 29,213 | 216,935 |
| 15:59:54 | 30.11 | 100 | 187,722 |
| 15:59:53 | 30.17 | 101 | 187,622 |
| 15:59:51 | 30.18 | 200 | 187,521 |
| 15:59:50 | 30.18 | 200 | 187,321 |
| 15:59:50 | 30.18 | 100 | 187,121 |
| 15:59:50 | 30.17 | 100 | 187,021 |
| 15:59:50 | 30.04 | 200 | 186,921 |
| 15:59:50 | 30.18 | 100 | 186,721 |
| 15:59:49 | 30.14 | 112 | 186,621 |
Price Extremes
| 1 week | 26.52 |  | 30.35 |
| 1 month | 26.52 | | 33.56 |
| Current year | 16.5 | | 34.89 |
| 1 year | 2.45 | | 38.33 |
| 3 years | 2.01 | | 38.33 |
| 5 years | 2.01 | | 112.5 |
| 10 years | 2.01 | | 449.75 |
Monthly variations
Annual variations
| 2026 | +30.64% | ||
| 2025 | +394.84% | ||
| 2024 | -74.17% | ||
| 2023 | -37.39% | ||
| 2022 | -62.05% | ||
| 2021 | -75.78% | ||
| 2020 | -16.60% |
- Stock Market
- Stocks
- DMRA Stock
- Quotes Damora Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
